Literature DB >> 1842674

Fatal toxic epidermal necrolysis during suramin therapy.

E May, B Allolio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1842674     DOI： 10.1016/0277-5379(91)90118-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.

Authors:  M A Villalona-Calero; G A Otterson; M G Wientjes; F Weber; T Bekaii-Saab; D Young; A J Murgo; R Jensen; T-K Yeh; Y Wei; Y Zhang; C Eng; M Grever; J L-S Au
Journal:  Ann Oncol       Date:  2008-07-15       Impact factor: 32.976

2.  Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.

Authors:  Elaine T Lam; Jessie L-S Au; Gregory A Otterson; M Guillaume Wientjes; Ling Chen; Tong Shen; Yong Wei; Xiaobai Li; Tanios Bekaii-Saab; Anthony J Murgo; Rhonda R Jensen; Michael Grever; Miguel A Villalona-Calero
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-28       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.